Monitoring of minimal residual disease in patients with acute myeloid leukemia (AML) and translocation (8;21) or inversion (16) by reverse transcriptase polymerase chain reaction (RT-PCR)

被引：0
|
作者：
Schafthausen, P
Schoch, R
Haferlach, T
Nickelsen, M
Jenisch, S
Kronke, M
Gassmann, W
Loffler, H
机构：
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,W-2300 KIEL,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT IMMUNOL,W-2300 KIEL,GERMANY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [1] Reverse transcriptase polymerase chain reaction (RT-PCR)
    Kendall, LV
    Riley, LK
    CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE, 2000, 39 (01): : 42 - 42
  • [2] Qualitative and quantitative RT-PCR in monitoring of minimal residual disease in acute myeloblastic leukemia with translocation t(8;21)
    Fleishman, EV
    Kosorukova, IS
    Sokova, OI
    Popa, AV
    Baturina, YA
    Misyurina, OY
    Ilyina, EN
    Govorun, VM
    Kirichenko, OP
    Konstantinova, LN
    Maschan, AA
    Maschan, MA
    Novichkova, GA
    Baidildina, DD
    Shamansky, SV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2006, 51 (01): : 3 - 12
  • [3] Detection of minimal residual disease (MRD) by RT-PCR in childhood acute myeloid leukemia (AML).
    Viehmann, S
    Creutzig, U
    Borkhardt, A
    Blütters-Sawatzki, R
    Harbott, J
    BLOOD, 1999, 94 (10) : 215B - 215B
  • [4] Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR
    Tobal, K
    Yin, JAL
    LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) : 115 - 120
  • [5] Bone marrow smears are suitable for the detection of minimal residual disease (MRD) by reverse transcriptase polymerase chain reaction (RT-PCR)
    Schoch, R
    Schafhausen, P
    Haferlach, T
    Jenisch, S
    Kronke, M
    Gassmann, W
    Loffler, H
    BLOOD, 1995, 86 (10) : 3102 - 3102
  • [6] Monitoring of minimal residual disease (MRD) by RT-PCR in childhood acute myeloid leukemia (AML) with AML1/ETO rearrangement
    Viehmann, S
    Creutzig, U
    Borkhardt, A
    Harbott, J
    LEUKEMIA, 2001, 15 (12) : 2025 - 2025
  • [7] Monitoring minimal residual disease in patients with AML M2 and t(8;21) by quantitative RT-PCR
    Tobal, K
    Yin, JL
    BLOOD, 1995, 86 (10) : 1311 - 1311
  • [8] Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.
    Marcucci, G
    Caligiuri, MA
    Oberkircher, AR
    Bloomfield, CD
    BLOOD, 1997, 90 (10) : 270 - 270
  • [9] DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) ON BONE-MARROW SMEARS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION (RT-PCR)
    HAFERLACH, T
    SCHOCH, R
    SCHATHAUSEN, P
    JENISCH, S
    GASSMANN, W
    KRONKE, M
    LOFFLER, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 762 - 762
  • [10] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).
    Perea, G
    Lasa, A
    Aventin, A
    Domingo, A
    Villamor, N
    de Llano, MPQ
    Llorente, A
    Junca, J
    Palacios, C
    Fernandez, C
    Gilallart, M
    Font, L
    Tormo, M
    Florensa, L
    Bargay, J
    Marti, JM
    Vivancos, P
    Torres, P
    Berlanga, J
    Brunet, S
    Sierra, J
    Nomdedeu, JF
    BLOOD, 2004, 104 (11) : 817A - 817A
12345